Multiple drugsLack of efficacy following compassionate use in unapproved route of administration

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2013卷 / 1期

关键词：

D O I：

10.1007/s40278-024-61316-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：302 / 302

相关论文

共 50 条

[1] Multiple drugsLack of efficacy and compassionate use
Reactions Weekly, 2024, 1999 (1) : 256 - 256
[2] Multiple drugsLack of efficacy and compassionate use: case report
Reactions Weekly, 2025, 2050 (1) : 377 - 377
[3] Multiple drugsLack of efficacy, and acute kidney injury following compassionate use of tisagenlecleucel: case report
Reactions Weekly, 2022, 1888 (1) : 256 - 256
[4] Multiple drugsLack of efficacy, various toxicities and compassionate use : case report
Reactions Weekly, 2022, 1925 (1) : 354 - 354
[5] Multiple drugsLack of efficacy and myocardial-infarction and radial thrombosis following compassionate use: case report
Reactions Weekly, 2022, 1919 (1) : 406 - 406
[6] Multiple drugsLack of efficacy and off-label use in unapproved indication: case report
Reactions Weekly, 2024, 2028 (1) : 336 - 336
[7] Multiple drugsLack of efficacy following off label use
Reactions Weekly, 2024, 2010 (1) : 278 - 278
[8] Multiple drugsLack of efficacy and off-label use (in unapproved indication): 4 case reports
Reactions Weekly, 2023, 1966 (1) : 245 - 245
[9] Multiple drugsLack of efficacy and opioid withdrawal syndrome following inadvertent administration of subcutaneous route instead of intrathecal: case report
Reactions Weekly, 2025, 2047 (1) : 286 - 286
[10] BleomycinTumour necrosis following off-label use in unapproved route of administration: case report
Reactions Weekly, 2023, 1941 (1) : 113 - 113

← 1 2 3 4 5 →